China Health Group Limited (HKG:0673)
0.4150
0.00 (0.00%)
Jul 7, 2026, 3:30 PM HKT
China Health Group Revenue
In the fiscal year ending March 31, 2026, China Health Group had annual revenue of 41.09M HKD with 5.52% growth. China Health Group had revenue of 21.48M in the half year ending March 31, 2026, a decrease of -32.15%.
Revenue
41.09M
Revenue Growth
+5.52%
P/S Ratio
14.01
Revenue / Employee
370.20K
Employees
111
Market Cap
575.66M
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 41.09M | 2.15M | 5.52% |
| Mar 31, 2025 | 38.94M | -20.99M | -35.02% |
| Mar 31, 2024 | 59.93M | -16.48M | -21.57% |
| Mar 31, 2023 | 76.41M | -30.61M | -28.60% |
| Mar 31, 2022 | 107.03M | 19.14M | 21.77% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Charmacy Pharmaceutical | 4.88B |
| ETHK Labs | 3.14B |
| Lung Fung Group Holdings | 2.46B |
| Sinco Pharmaceuticals Holdings | 2.32B |
| Sipai Health Technology | 2.30B |
| ClouDr Group | 1.81B |
| 160 Health International | 725.41M |
| Ziyuanyuan Holdings Group | 535.97M |